The Massachusetts-based company's 'hybrid closed-loop insulin pump', the Omnipod Horizon, demonstrated effective blood glucose control and safety in a 36-hour study involving 24 type 1 diabetes ...

Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at three upcoming ...

Insulet ( (PODD) ) has released its Q3 earnings. Here is a breakdown of the information Insulet presented to its investors. Insulet ...

(Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced plans to recognize National Diabetes Awareness Month and ...

November 15, 2024--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology ... life for people with diabetes and other conditions ...

Tandem Diabetes Care (TNDM) and Insulet (PODD) stocks draw outperform ratings at Bernstein as insulin pump makers prepare for ...

--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology ... for both type 1 and type 2 diabetes, following recent ...

Insulet is very vulnerable if larger competitors produce similar or superior tubeless insulin pumps. When consumers pull back on spending, we've seen some diabetic patients put off purchases of ...